Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Lidocaine - Generic Drug Details

« Back to Dashboard
Lidocaine is the generic ingredient in forty-four branded drugs marketed by Belmora Llc, Septodont Inc, Teikoku Pharma Usa, Teligent Pharma Inc, Taro, Astrazeneca, Carlisle, Mylan Technologies, Noven, Actavis Labs Ut Inc, Amneal Pharms, Fougera, Glenmark Pharms Ltd, Intl Medication, Fresenius Kabi Usa, Hospira, West-ward Pharms Int, Graham Chem, Abraxis Pharm, Vintage, Bel Mar, Miles, Hi Tech Pharma, Powder Pharms, Oak Pharms, G And W Labs Inc, Akorn, Elkins Sinn, Watson Labs, Pharmaton, Bionpharma Inc, B Braun, Kendall Il, Gd Searle Llc, Watson Labs Inc, Aurobindo Pharma Ltd, Mylan Labs Ltd, Meridian Medcl Techn, Luitpold, Abbott, Baxter Hlthcare, Luitpold Pharms Inc, Wockhardt, Actavis Mid Atlantic, Dentsply Pharm, Wyeth Ayerst, Dell Labs, Paco, Lyphomed, Sagent Pharms, Pfizer, Tolmar, Fougera Pharms, Galderma Labs Lp, and Galen Specialty, and is included in one hundred and twenty-four NDAs. There are seventeen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has eight patent family members in seven countries.

There are twenty-nine drug master file entries for lidocaine. Thirty-eight suppliers are listed for this compound.

Summary for Generic Name: lidocaine

Drug Master File Entries: see list29
Suppliers / Packagers: see list38
Bulk Api Vendors: see list71
Clinical Trials: see list376
Patent Applications: see list23,147
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: lidocaine

Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
lidocaine hydrochloride
INJECTABLE;INJECTION083158-003Approved Prior to Jan 1, 1982RXNo► subscribe► subscribe
Intl Medication
lidocaine hydrochloride
SOLUTION;TOPICAL086364-001Approved Prior to Jan 1, 1982RXNo► subscribe► subscribe
Glenmark Pharms Ltd
OINTMENT;TOPICAL206498-001Sep 9, 2016RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lidocaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
PATCH;TOPICAL020575-002May 21, 19965,332,576► subscribe
Teikoku Pharma Usa
PATCH;TOPICAL020612-001Mar 19, 19995,741,510► subscribe
FILM, EXTENDED RELEASE;BUCCAL020575-001May 21, 19965,234,957► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lidocaine

Country Document Number Estimated Expiration
JapanH04305523► subscribe
Canada2064325► subscribe
Japan3115625► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.